< Back to previous page
Researcher
Gabriele Bergers
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Other basic sciences not elsewhere classified
Affiliations
- Laboratory for Tumor Microenvironment and Therapeutic Resistance (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - Bergers Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory for Tumor Microenvironment and Therapeutic Resistance (VIB-KU Leuven) (Division)
Member
From1 Aug 2016 → Today
Projects
1 - 10 of 27
See also Gabriele Bergers for projects of Flanders Institute for Biotechnology.
Here below the projects of KU Leuven.
- Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven Flow Cytometry core facilityFrom1 Jan 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven Flow Cytometry core facilityFrom1 Jan 2025 → TodayFunding: BOF - scientific equipment program
- Hemorrhage-induced HO-1 macrophages infer resistance to antiangiogenic immunotherapies in cancerFrom1 Jan 2025 → TodayFunding: Foundations, funds and other with scientific goal
- Targeting the Treg – macrophage axis to promote immune stimulation and tertiary lymphoid structure formation in IDHwt GBM TME subtypesFrom25 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the role of vascular remodeling in premetastatic and metastatic lymph nodesFrom25 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → 31 Dec 2024Funding: BOF - scientific equipment program
- Golden-NK: employing gold-mediated thermal heating for improved and safe immunotherapyFrom1 Oct 2022 → TodayFunding: BOF - projects
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Imaging the invisible in preclinical models using magnetic particle imagingFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Immune functions and regulation of high-endothelial venulesFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 38
See also Gabriele Bergers for publications of Flanders Institute for Biotechnology.
Here below the publications of KU Leuven.
- Murine vascular organoids are responsive and adaptable 3D systems with cellular heterogeneity and dynamic plasticity(2025)Published in: Science AdvancesISSN: 2375-2548Issue: 43Volume: 11
- Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment(2025)Published in: CELL REPORTS MEDICINEISSN: 2666-3791Issue: 10Volume: 6
- Guidelines for the assessment of high endothelial venule functionality and health.(2025)Published in: Methods in Cell BiologyISSN: 0091-679XVolume: 196Pages: 1 - 15
- The Pan-Tumor Vasculature under the Transcriptomic Magnifying Glass(2024)Published in: CANCER RESEARCHISSN: 0008-5472Issue: 21Volume: 84Pages: 3502 - 3504
- Targeting the tumour vasculature: from vessel destruction to promotion(2024)Published in: Nature Reviews. CancerISSN: 1474-175XIssue: 10Volume: 24Pages: 655 - 675
- An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade(2024)Published in: Cell ReportsISSN: 2211-1247Issue: 4Volume: 43
- The ins and outs of microglial cells in brain health and disease(2024)Published in: Frontiers in ImmunologyISSN: 1664-3224Volume: 15
- Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma(2023)Published in: EMBO Molecular MedicineISSN: 1757-4676Issue: 12Volume: 15
- Unraveling the ontogeny, regulation and function of intratumoral high endothelial venules to enhance immunotherapy(2023)
- Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)Published in: Science Translational MedicineISSN: 1946-6234Issue: 691Volume: 15